G 1 cells after a 24 h exposure (cell cycle time 12 h) and continues to increase with drug-exposure time. We have found, however, that if the drug is removed at 24 h, the cells will divide and begin to proliferate. Two hundred cells treated in this way were plated out into Petri dishes at a concentration of 1 cell/dish, immediately after exposure to the drug. The dishes were incubated for 3 weeks at 370C and then examined for cell colonies. It was found that, of the 10% of the cells surviving the cytotoxic effects of the drug, 95% were polyploid, with double the usual complement of DNA present in untreated EMT6 cells. One of these polyploid cell lines was selected as a representative sample for further investigation and cloned out once more. This was to ensure as far as possible that the resulting polyploid cell line was derived from a single cell.
The DNA contents of the cells were measured by flow cytofluorimetry (FCF). Cells are stained with a fluorescent DNA coupling agent, propidium iodide (Krishan, 1975) However, the DNA content is twice normal and all cells have a ploidy of 6-12n. The mean diameter of the polyploid cells was found to be 1-3 that of the normal EMT6 cells, which in terms of cell volume represents a factor of 2.
The chromosome contents of the in vitro normal and polyploid cell lines are shown in Fig. 2 Cells of the EMT6 in vrio cell line were treated in vivo to determine whether polyploid cells produced by Razoxane were capable of growing as a solid tumour. Two hundred drug-treated cells were cloned into Petri dishes, and 12% survived the drug treatment to form cell colonies. All subsequent cell populations arising from these clones were found to be capable of growing as a solid tumour when inoculated into BALB/c mice, and of these, 92% had twice the normal EMT6 DNA content. Again one of the polyploid cell lines was selected for further investigation and cloned once more. Fig. 1(c) shows the DNA content of a normal EMT6 solid tumour. The first peak represents mouse diploid cells, macrophages and lymphocytes, found in this tumour. The tumour cells have a 3-6n DNA content and most of the cells are in G 1. The corresponding polyploid tumour is shown in Fig. 1 (d) , and although the diploid peak is present, no tumour cells with a 3n DNA content are found. All the tumour cells have a 6-12n DNA content.
The growth of normal and polyploid tumours was compared (Fig. 4) no similarity is implied for the more complex kinetic parameters of cell-cycle time, growth fraction or cell-loss factors. Both the in vitro and in vivo polyploid cell lines have been routinely passaged since their origin some 6 months ago. In terms of DNA content, chromosome number and growth characteristics, both of these cell lines have remained stable over this period.
By further treatment of the polyploid cells with Razoxane, cell populations containing 4 x the normal DNA content can be obtained, but we are as yet unable to comment on the stability of these cells.
Many studies have been made on the effects of gene dosage on specific aspects of cell behaviour and function. The higher plants have been most commonly used in this work due to their large intra-specific variation in ploidy (Underbrink and Pond, 1976) . In comparison, the variation in ploidy within mammalian species is relatively small. It is possible to select out polyploid variants of some mammalian tumour cell lines (Millar and Miller, 1977) (Kleinfeld and Sisken, 1966; Palitti and Rizzoni, 1972; Rizzoni and Palitti, 1973) and cytochalasin B (Carter, 1967; Defendi and Stoker, 1973) have previously been reported to induce stable polyploid mammalian cell lines, which are also capable of growing in vivo in a suitable host. Unlike these 3 agents, Razoxane is used clinically as a chemotherapeutic agent alone or in combination with radiotherapy, as a treatment for human neoplasms. Ifthe polyploid cells produced by Razoxan, prove to be resistant to either further drug challenge or to radiotherapy, they could provide the foci for tumour regrowth after treatment. It is important, therefore, that the relative sensitivity of these polyploid cells, to both drugs and radiation is examined.
